---
name: Raybow USA, Inc.
slug: raybow
site: cdmo
website_domain: raybow.com
summary: Chemical CDMO in Brevard, North Carolina offering custom organic synthesis, process development, analytical services, tech transfer, and cGMP production for small molecules and specialty chemicals. The site cites FDA-inspected facilities and multi-kg commercial API supply. Headquartered in Brevard, United States.
tagline: Molecule to Market: Your Trusted Partner
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: Jiuzhou Pharma
parent_slug: jiuzhoupharma
hq_country: US
tier2_domain_verified: false
updated_at: 2026-10-26T11:01:04.213Z
services_count: 5
modalities_count: 1
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Raybow USA, Inc.

Molecule to Market: Your Trusted Partner

Listed on cdmo.directory.

## Summary

Chemical CDMO in Brevard, North Carolina offering custom organic synthesis, process development, analytical services, tech transfer, and cGMP production for small molecules and specialty chemicals. The site cites FDA-inspected facilities and multi-kg commercial API supply. Headquartered in Brevard, United States.

## At a glance

- Parent: [Jiuzhou Pharma](/companies/jiuzhoupharma)
- HQ country: US

## Services

- API Synthesis & Manufacturing
- Process Development
- Analytical Method Development & Validation
- Technology Transfer
- Small Molecule Development & Manufacturing

## Modalities

- Small Molecule

## Locations

- Brevard, North Carolina (Headquarters), Brevard, North Carolina, United States

## Long description

Raybow USA, Inc. is a subsidiary of Jiuzhou Pharma and operates as a chemical contract development and manufacturing organization (CDMO) based in Brevard, North Carolina.

## Services

- Custom organic synthesis for small molecules, specialty chemicals, and polymers
- Process development and tech transfer
- Analytical services, with synthetic and analytical labs described as collaborating on projects
- cGMP pharmaceutical and specialty chemical production
- Research and development support, from benchtop R&D to production

## Capabilities

- Multi-kg scale commercial API production from Brevard facilities, per the company's About page
- PhD chemists working in project teams
- Project management team and flexible contract formats

## Quality and Regulatory

- The site states that its facilities have been FDA inspected
- The company states it has repeatedly passed EHS audits from multinational pharmaceutical companies

## Global Network

Raybow USA is part of the Jiuzhou Pharma global CDMO, which describes facilities and chemists in North America, Europe, and China. Raybow USA customers are described as having access to these international experts and facilities.

## Related companies

- [PHT International, Inc.](/companies/phtinternational) (API Synthesis & Manufacturing, Process Development) — [Compare](/compare/phtinternational/raybow)
- [Lacamas Laboratories Inc.](/companies/lacamaslabs) (API Synthesis & Manufacturing, Process Development) — [Compare](/compare/lacamaslabs/raybow)
- [ARSI Canada Inc](/companies/arsicanada) (API Synthesis & Manufacturing, Process Development) — [Compare](/compare/arsicanada/raybow)
- [Hikal](/companies/hikal) (API Synthesis & Manufacturing, Process Development) — [Compare](/compare/hikal/raybow)
- [DSK InnoSciences Ltd](/companies/dskinnosciences) (API Synthesis & Manufacturing, Process Development) — [Compare](/compare/dskinnosciences/raybow)
- [Winkem Labs Pvt. Ltd.](/companies/winkemlabs) (API Synthesis & Manufacturing, Process Development) — [Compare](/compare/raybow/winkemlabs)
- [Laurus Labs](/companies/lauruslabs) (API Synthesis & Manufacturing, Process Development) — [Compare](/compare/lauruslabs/raybow)
- [SEQENS](/companies/seqens) (API Synthesis & Manufacturing, Process Development) — [Compare](/compare/raybow/seqens)

_Profile last updated: 2026-10-26T11:01:04.213Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.